PDMR/Director Dealing

RNS Number : 1870O
Omega Diagnostics Group PLC
08 June 2022
 

OMEGA DIAGNOSTICS GROUP PLC

("Omega" or the "Company" or the "Group")

PDMR/Director Dealing

Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Health & Nutrition and Global Health products, announces that, following the general meeting held on 6 June 2022 and Admission on 8 June 2022, the following Directors participated in the Fundraising and their resultant holdings are detailed in the table below.

 

Director

Board Position

Number of Subscription Shares at the Issue Price

Amount (£)

Resultant holding

Resultant percentage holding of Enlarged Issued Share Capital

Simon Douglas1

Chairman

500,000

2 0,000

500,000

0.21%

Jag Grewal2

CEO

500,000

20,000

735,746

0.31%

Chris Lea3

CFO

500,000

20,000

500,000

0.21%

Jeremy Millard4

Non-Executive Director

500,000

20,000

1,025,000

0.43%

 

Capitalised terms not otherwise defined in the text of this announcement have the meanings given to them in the Company's circular dated 13 May 2022.

 

Contacts: 

Omega Diagnostics Group PLC 

www.omegadx.com

Jag Grewal, Chief Executive Officer 

via Walbrook PR

Chris Lea, Chief Financial Officer




finnCap Ltd  

Tel: 020 7220 0500

Geoff Nash/Edward Whiley/George Dollemore (Corporate Finance)


Alice Lane/ Harriet Ward (ECM)




Walbrook PR Limited

Tel: 020 7933 8780 or omega@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Applegarth

Mob: 07584 391 303

Sam Allen

Mob: 07502 558 258

 

 

About Omega Diagnostics Group PLC

Omega manufactures and distributes high quality in-vitro diagnostic products for use in hospitals, clinics, laboratories and healthcare practitioners in over 70 countries and specialise in the areas of health and nutrition and global health.

www.omegadx.com

 

 

Notification of transactions of persons discharging managerial responsibilities and persons closely associated with them

 

1  

Details of the person discharging managerial responsibilities / person closely associated  

a)

 

Name

 

 

1)  Simon Douglas

2)  Jag Grewal

3)  Chris Lea

4)  Jeremy Millard

2

Reason for the notification

a)

 

Position/status

 

 

1)  Chairman

2)  Chief Executive Officer

3)  Chief Financial Officer

4)  Non-Executive Director

b)

Initial notification /Amendment 

Initial Notification

3  

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) 

Name 

Omega Diagnostics Group Plc

b) 

LEI 

2138007U9P4BTZTYIR92

4  

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  

a)

 

Description of the financial instrument, type of instrument

 Identification code 

Ordinary Shares of 4 pence each 

 

 ISIN: GB00B1VCP282

b) 

Nature of the transaction 

Purchase of Shares

c)

 

Price(s) and volume(s)

 

 


Price(s)

Volume(s)

1)

£0.04

500,000

2)

£0.04

500,000

3)

£0.04

500,000

4)

£0.04

500,000

 

d)

Aggregated information 

-Aggregated volume 

- Price 

N/A - single transaction for each Director or PCA

 

e) 

Date of the transaction

 6 May 2022

f) 

Place of the transaction

London Stock Exchange (AIM)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBKFBQBBKDAAK
UK 100

Latest directors dealings